Eisai
4523.T
#2122
Rank
$7.67 B
Marketcap
$27.20
Share price
-2.42%
Change (1 day)
-35.81%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $1.00

According to Eisai's latest financial reports the company's current EPS (TTM) is $1.00. In 2024 the company made an earnings per share (EPS) of $0.98 a decrease over its 2023 EPS that were of $1.45.

EPS history for Eisai from 2000 to 2023

Annual EPS

Year EPS Change
2024$0.98-32.7%
2023$1.455.87%
2022$1.37-74.17%
2021$5.31-66.28%
2020$15.7497.28%
2019$7.9817.01%
2018$6.8238.41%
2017$4.93-28.03%
2016$6.8435.46%
2015$5.05-3.12%
2014$5.21-27.44%
2013$7.19-27.49%
2012$9.91-12.89%
2011$11.3887.89%
2010$6.06-10.47%
2009$6.76-382.34%
2008-$2.40-128.46%
2007$8.4211.74%
2006$7.533.91%
2005$7.258.41%
2004$6.6942.65%
2003$4.6924.86%
2002$3.7652.67%
2001$2.4666.47%
2000$1.48